Loading institutional data...
Loading institutional data...
Strong institutional distribution: ownership decreased -6.95% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
The answer is outside the range this solves over (-60% to +100%/yr), so it is reported as off the scale rather than as a rate. The price is below what this cash flow is worth even under collapse.
2-stage DCF · 0.11B shares · net debt -$31M
mean 8.3% · volatility σ 79% · implied rate exceeded in 6/8 yrs
Central path = implied -60.0%/yr growth; shaded band = ±1σ (79%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-14
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $376.9M 100.0% | $617.6M 100.0% | $716.3M 100.0% | $766.9M 100.0% | $776.3M 100.0% | $644.3M 100.0% | $410.9M 100.0% | $321.1M 100.0% | $255.1M 100.0% | $254.1M 100.0% |
| Cost of Revenue | $152.2M 40.4% | $180.9M 29.3% | $225.9M 31.5% | $197.4M 25.7% | $254.9M 32.8% | $205.4M 31.9% | $92.2M 22.4% | $80.0M 24.9% | $80.2M 31.4% | $119.6M 47.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $0 0.0% | $34.8M 13.7% |
| Cost of Services | — | — | — | — | — | — | — | — | $80.2M 31.4% | $56.2M 22.1% |
| Gross Profit | $224.8M 59.6% | $436.6M 70.7% | $490.4M 68.5% | $569.5M 74.3% | $521.4M 67.2% | $438.9M 68.1% | $318.7M 77.6% | $241.1M 75.1% | $174.9M 68.6% | $134.5M 52.9% |
| Research & Development | $93.5M 24.8% | $170.4M 27.6% | $191.7M 26.8% | $196.6M 25.6% | $178.8M 23.0% | $170.9M 26.5% | $139.8M 34.0% | $114.3M 35.6% | $81.9M 32.1% | $66.3M 26.1% |
| Selling, General & Admin | $177.4M 47.1% | $217.8M 35.3% | $236.2M 33.0% | $216.2M 28.2% | $159.0M 20.5% | $129.3M 20.1% | $97.6M 23.7% | $77.7M 24.2% | $64.4M 25.3% | $55.4M 21.8% |
| Total Operating Expenses | $341.6M 90.6% | $1.17B 190.1% | $558.1M 77.9% | $560.5M 73.1% | $443.3M 57.1% | $382.2M 59.3% | $300.9M 73.2% | $247.3M 77.0% | $193.9M 76.0% | $174.6M 68.7% |
| Operating Income | -$116.9M -31.0% | -$737.1M -119.4% | -$67.7M -9.5% | $9.0M 1.2% | $78.1M 10.1% | $56.8M 8.8% | $17.8M 4.3% | -$6.2M -1.9% | -$19.0M -7.4% | -$40.1M -15.8% |
| Interest Expense | $590K 0.2% | $2.6M 0.4% | $3.8M 0.5% | $6.0M 0.8% | — | — | — | — | — | — |
| Other Income (Expense), net | $16.7M 4.4% | $48.7M 7.9% | $118.0M 16.5% | $95.0M 12.4% | -$72.4M -9.3% | -$57.6M -8.9% | -$24.8M -6.0% | -$7.2M -2.3% | $486K 0.2% | -$468K -0.2% |
| Pretax Income | -$100.1M -26.6% | -$688.4M -111.5% | $50.3M 7.0% | $103.9M 13.6% | $5.7M 0.7% | -$861K -0.1% | -$7.0M -1.7% | -$13.5M -4.2% | -$18.5M -7.2% | -$40.5M -16.0% |
| Income Tax Expense | $3.3M 0.9% | $148.7M 24.1% | $32.1M 4.5% | -$162.7M -21.2% | $7.2M 0.9% | $5.4M 0.8% | $2.6M 0.6% | $1.4M 0.4% | $1.8M 0.7% | $1.7M 0.7% |
| Net Income | -$103.0M -27.3% | -$837.0M -135.5% | $18.0M 2.5% | $266.6M 34.8% | -$1.5M -0.2% | -$6.2M -1.0% | -$9.6M -2.3% | -$14.9M -4.6% | -$20.3M -8.0% | -$42.2M -16.6% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.96 | $-8.10 | $0.16 | $2.09 | $-0.01 | $-0.05 | $-0.08 | — | — | — |
| EPS (Diluted) | $-0.96 | $-8.10 | $-0.34 | $1.34 | $-0.01 | $-0.05 | $-0.08 | — | — | — |
| Weighted Avg Shares (Basic) | 107.5M | 103.3M | 116.5M | 127.6M | 141.3M | 125.4M | 119.2M | — | — | 90.5M |
| Weighted Avg Shares (Diluted) | 107.5M | 103.3M | 128.6M | 149.9M | 141.3M | 125.4M | 119.2M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$13M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -86%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-14
Where each multiple sits in its own 13-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 13-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.2× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 24.9 | 22.4 | 31.9 | 32.8 | 25.7 | 31.5 | 29.3 | 40.4 |
| Gross Profit | 75.1 | 77.6 | 68.1 | 67.2 | 74.3 | 68.5 | 70.7 | 59.6 |
| R&D | 35.6 | 34.0 | 26.5 | 23.0 | 25.6 | 26.8 | 27.6 | 24.8 |
| SG&A | 24.2 | 23.7 | 20.1 | 20.5 | 28.2 | 33.0 | 35.3 | 47.1 |
| Operating Income | -1.9 | 4.3 | 8.8 | 10.1 | 1.2 | -9.5 | -119.4 | -31.0 |
| Income Tax | 0.4 | 0.6 | 0.8 | 0.9 | -21.2 | 4.5 | 24.1 | 0.9 |
| Net Income | -4.6 | -2.3 | -1.0 | -0.2 | 34.8 | 2.5 | -135.5 | -27.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CHGG: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $870.8B | 40.0× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $407.3B | 50.5× | 31.1× | 1.5× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $384.5B | 29.4× | 25.3× | 8.0× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $343.4B | 22.4× | 16.2× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $303.2B | 26.8× | 17.7× | 7.5× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $186.6B | 22.7× | 15.2× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $118.2B | 17.1× | 13.7× | 5.1× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.7B | 33.0× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $71.9B | 19.5× | 10.4× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.4B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.2B | — | 16.2× | 5.2× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.9B | 20.6× | 14.4× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $41.8B | 38.8× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.3B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $41.1B | — | — | — | — | — | — | — | — | — | 241 |
| SYY | $40.8B | 22.4× | 10.2× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KR | $39.7B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| EL | $35.4B | — | 803.9× | 2.5× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| HSY | $35.2B | — | 20.6× | 3.0× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| KVUE | $34.3B | 23.6× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| KMB | $32.9B | 16.3× | 10.4× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.1B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $28.4B | 18.9× | 8.4× | 0.7× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| DLTR | $23.7B | 19.2× | 11.0× | 1.2× | 10.4% | 36.3% | 6.6% | 34.2% | 20.7% | 1.1× | 819 |
| KOF | $23.5B | — | — | — | — | — | — | — | — | — | 249 |
| CHGG | $84M | — | — | 0.2× | -39.0% | 59.6% | -27.4% | -86.5% | -86.5% | — | 99 |
Peers = companies sharing CHGG's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.